Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Org Biomol Chem ; 21(38): 7776-7781, 2023 Oct 04.
Article in English | MEDLINE | ID: mdl-37701943

ABSTRACT

A highly efficient and operationally simple method for the synthesis of ß-sulfinyl alkenylsulfones through a BF3·OEt2-promoted reaction of alkynes and sodium sulfinates is developed, successfully avoiding the complicated anhydrous treatment before the reaction and greatly simplifying the reaction conditions. As a facile and selective route to the targets, it features good functional group compatibility, mild conditions, easily available starting materials, and excellent yields. Notably, the trace water in solvent plays a key role in promoting the reaction, which provides a more practical pathway for the utilization of the BF3·OEt2 catalytic system.

2.
Neuroreport ; 31(2): 167-173, 2020 01 27.
Article in English | MEDLINE | ID: mdl-31789691

ABSTRACT

The present study examined the roles of 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes in mediating the ventrolateral orbital cortex (VLO)-induced antiallodynia in a rat model of neuropathic pain induced by spared nerve injury (SNI). Change of mechanical paw withdrawal threshold (PWT) was measured using von-Frey filaments. Microinjection of preferential or selective 5-HT2A/C, 5-HT2B and 5-HT2C receptor agonists, (±)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI), α-methyl-5-(2-thienylmethoxy)-1H-Indole-3-ethanamine hydrochloride (BW723C86) and 1-(3-Chlorophenyl)-piperazine hydrochloride (m-CPP) into the VLO significantly depressed allodynia induced by SNI, and the inhibitory effect of DOI was blocked or attenuated by selective 5-HT2A/C receptor antagonists ketanserin (+)-tartrate salt (ketanserin) and 5-HT2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (M100907); the effects of BW723C86 and m-CPP were antagonized by 5-HT2B receptor antagonists N-(1-Methyl-1H-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea (SB204741) and 5-HT2C receptor antagonist RS102221 hydrochloride hydrate (RS-102221), respectively. These results suggest that 5-HT2A, 5-HT2B, 5-HT2C receptor subtypes are involved in mediating the VLO-induced antiallodynia in the neuropathic pain state.


Subject(s)
Hyperalgesia/drug therapy , Prefrontal Cortex/drug effects , Receptor, Serotonin, 5-HT2A/drug effects , Receptor, Serotonin, 5-HT2B/drug effects , Receptor, Serotonin, 5-HT2C/drug effects , Animals , Hyperalgesia/chemically induced , Indoles/pharmacology , Male , Neuralgia/chemically induced , Neuralgia/drug therapy , Rats, Sprague-Dawley , Spiro Compounds/pharmacology , Sulfonamides/pharmacology , Urea/analogs & derivatives , Urea/pharmacology
3.
RSC Adv ; 8(20): 10806-10817, 2018 Mar 16.
Article in English | MEDLINE | ID: mdl-35541536

ABSTRACT

Polymer materials with electrically conductive properties have good applications in their respective fields because of their special properties. However, they usually exhibited poor mechanical properties and biocompatibility. In this work, we present a simple approach to prepare conductive sodium alginate (SA) and carboxymethyl chitosan (CMCS) polymer hydrogels (SA/CMCS/PPy) that can provide sufficient help for peripheral nerve regeneration. SA/CMCS hydrogel was cross-linked by calcium ions provided by the sustained release system consisting of d-glucono-δ-lactone (GDL) and superfine calcium carbonate (CaCO3), and the conductivity of the hydrogel was provided by doped with polypyrrole (PPy). Gelation time, swelling ratio, porosity and Young's modulus of the conductive SA/CMCS/PPy hydrogel were adjusted by polypyrrole content, and the conductivity of it was within 2.41 × 10-5 to 8.03 × 10-3 S cm-1. The advantages of conductive hydrogels in cell growth were verified by controlling electrical stimulation of cell experiments, and the hydrogels were also used as a filling material for the nerve conduit in animal experiments. The SA/CMCS/PPy conductive hydrogel showed good biocompatibility and repair features as a bioactive biomaterial, we expect this conductive hydrogel will have a good potential in the neural tissue engineering.

4.
Brain Res ; 1652: 151-157, 2016 12 01.
Article in English | MEDLINE | ID: mdl-27742468

ABSTRACT

Histone acetylation and other modifications of the chromatin are important regulators of gene expression and may contribute to drug-induced behaviors and neuroplasticity. Inhibition of histone deacetylases (HDAC) activity results in the change of some drug-induced behaviors,however, relatively little is known about the effects of HDAC inhibitors on heroin-seeking behavior. In the present study, male rats were trained to self-administer heroin under a FR1 schedule for consecutive 14 days, followed by 14 daily 2h extinction session in the operant chamber. After training, the heroin priming (250µg/kg) was introduced for the reinstatement of heroin-seeking behavior. Pretreatment with sodium butyrate (NaB) (200 or 400mg/kg, i.p.), an inhibitor of HDAC, failed to affect heroin self-administration. Additionally,systemic administration of NaB (400mg/kg, i.p.)increased significantly the reinstatement of heroin-seeking induced by heroin priming when NaB administered 12h, but not 6h before the reinstatement test. The same effect was observed after the intracerebroventricular injection of NaB (5µL, 100µg/µL). Moreover, the levels of histone H3 acetylation at lysine 18(H3K18)and H4 acetylation at lysine 5 or lysine 8(H4K5 or H4K8)in the accumbens nucleus core and shell were remarkably increased during the reinstatement and were further strengthened after intracerebroventricular injection of NaB. These results demonstrated that activation of histone acetylation may be involved in the heroin-seeking behavior, and identifying these epigenetic changes will be critical in proposing a novel pharmacological strategy for treating heroin addiction.


Subject(s)
Butyric Acid/pharmacology , Drug-Seeking Behavior/drug effects , Heroin Dependence/enzymology , Histone Deacetylase Inhibitors/pharmacology , Histones/drug effects , Nucleus Accumbens/drug effects , Acetylation/drug effects , Animals , Conditioning, Operant/drug effects , Conditioning, Operant/physiology , Dose-Response Relationship, Drug , Drug-Seeking Behavior/physiology , Epigenesis, Genetic/drug effects , Extinction, Psychological/drug effects , Extinction, Psychological/physiology , Heroin/administration & dosage , Heroin Dependence/genetics , Heroin Dependence/pathology , Histone Deacetylases/metabolism , Histones/genetics , Histones/metabolism , Infusions, Intraventricular , Male , Motor Activity/drug effects , Motor Activity/physiology , Narcotics/administration & dosage , Nucleus Accumbens/enzymology , Nucleus Accumbens/pathology , Random Allocation , Rats, Sprague-Dawley , Self Administration
5.
Neurosci Lett ; 574: 11-4, 2014 Jun 27.
Article in English | MEDLINE | ID: mdl-24813108

ABSTRACT

DNA methylation and histone modification are two major epigenetic mechanisms involved in the pathophysiology of major depressive disorder (MDD) and the action of antidepressants. We and others have recently shown that epigenetic regulation through histone acetylation within ventrolateral orbital cortex (VLO) contributes to the antidepressant-like effects of histone deacetylase inhibitors [HDACi, such as valproic acid (VPA) and MS-275] observed in rats. However, there is so far no investigation focused on the effect of DNA methylation in VLO on depressive-like behaviors. Here, we examined the effects of the DNA methyltransferases (DNMTs) inhibitor 5-aza-2-deoxycytidine (5-aza) on rat forced swimming test (FST) and locomotor activity when microinjected into VLO. We found that bilateral intra-VLO injections of 5-aza increased the duration of immobility in FST in a dose-dependent manner compared to vehicle-treated controls. The effects of 5-aza observed in the FST paradigms could not be attributed to non-specific decreases in activity since the inhibition of DNA methylation in VLO did not cause general impairment in locomotor activity. These results add to the evidence that DNA hypomethylation in VLO is involved in regulating depressive-like behaviors, and suggest that the effect of DNA methylation on depressive-like behaviors appear to be brain region-dependent.


Subject(s)
Azacitidine/analogs & derivatives , DNA Modification Methylases/antagonists & inhibitors , Depression/psychology , Prefrontal Cortex/drug effects , Animals , Azacitidine/pharmacology , DNA Methylation , Decitabine , Depression/metabolism , Depression/physiopathology , Male , Microinjections , Motor Activity/drug effects , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Rats, Sprague-Dawley
6.
Exp Neurol ; 248: 381-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23872512

ABSTRACT

The present study examined the role of α2 adrenoceptor in mediating noradrenaline action in the ventrolateral orbital cortex (VLO) on allodynia induced by spared nerve injury (SNI) in the rat. The mechanical paw withdrawal threshold (PWT) was measured using von-Frey filaments. Microinjection of noradrenaline (1, 2, 4 µg in 0.5 µl) into the VLO, contralateral to the site of nerve injury, reduced allodynia; PWT increased in a dose-dependent manner. Similar to noradrenaline, microinjection of selective α2 adrenoceptor agonist clonidine into the same VLO site also reduced allodynia, and was blocked by selective α2 adrenoceptor antagonist yohimbine. Furthermore, administration of γ-aminobutyric acid A (GABAA) receptor antagonist bicuculline or picrotoxin to the VLO significantly enhanced clonidine-induced inhibition of allodynia, while GABAA receptor agonist muscimol or THIP (2,5,6,7-retrahydroisoxazolo(5,4-c)pyridine-3-ol hydrochloride) attenuated clonidine-induced inhibition. These results suggest that noradrenaline acting in the VLO can potentially reduce allodynia induced by SNI, and this effect is mediated by α2 adrenoceptor. Moreover, GABAergic disinhibition may participate in α2 receptor mediating effects in neuropathic pain in the central nervous system.


Subject(s)
Cerebral Cortex/metabolism , Hyperalgesia/metabolism , Norepinephrine/metabolism , Receptors, Adrenergic, alpha-2/metabolism , Sciatic Neuropathy/metabolism , Adrenergic alpha-2 Receptor Agonists/pharmacology , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Animals , Bicuculline/pharmacology , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Clonidine/pharmacology , Dose-Response Relationship, Drug , GABA Antagonists/pharmacology , Hyperalgesia/physiopathology , Male , Pain Measurement , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley , Sciatic Nerve/drug effects , Sciatic Nerve/injuries , Sciatic Nerve/physiopathology , Sciatic Neuropathy/physiopathology , Yohimbine/pharmacology
7.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 28(12): 1265-8, 2012 Dec.
Article in Chinese | MEDLINE | ID: mdl-23232518

ABSTRACT

AIM: To construct the recombinant adenoviral vector which can efficiently inhibit mature miR-21 expression and explore its effects and the underlying mechanisms on hepatoma cell line HepG2. METHODS: Based on miRNA-sponge technology, we synthesized 8 duplicated fragments, fully complementary with the miR-21 sequence and cloned them into a shuttle vector pAdTrack-CMV. The constructed plasmid was sequenced and linearized for homologous recombination with pAdEasy-1 vector in BJ5183 bacteria, then transfected into 293A cells. The recombinant adenovirus was used to challenge HepG2 cells. Mature miR-21 level was detected by real-time PCR. Apoptosis and proliferation of the HepG2 cells were detected by Hochest 33258 staining, Western blotting and MTT assay. RESULTS: The restriction enzyme digestion, DNA sequencing and detection of GFP expression demonstrated that recombinant adenoviral vector was constructed successfully. The recombinant adenovirus inhibited the expression of miR-21 in HepG2 cells, and also depressed the proliferation of HepG2 cells and promoted the apoptosis. CONCLUSION: The recombinant adenoviral vector we successfully constructed could efficiently reduce the expression of miR-21 in HepG2 cells and depress the proliferation of HepG2 cells.


Subject(s)
Adenoviridae/physiology , Genetic Vectors/physiology , Liver Neoplasms/genetics , MicroRNAs/genetics , Virus Assembly , Adenoviridae/genetics , Apoptosis , Base Sequence , Cell Proliferation , Down-Regulation , Genetic Vectors/genetics , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/physiopathology , Liver Neoplasms/therapy , MicroRNAs/metabolism , MicroRNAs/therapeutic use , Molecular Sequence Data
8.
Chem Biodivers ; 4(9): 2198-209, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17886838

ABSTRACT

Three hydrazone ligands, H2L1-H2L3, made from salicylaldehyde and ibuprofen- or naproxen-derived hydrazides, were prepared and transformed into the corresponding copper(II) complexes [Cu(II)L1] x H2O, [Cu(II)L2], and [(Cu(II))2(L3)2] x H2O x DMF (Scheme). The X-ray crystal structure of the last-mentioned complex was solved (Fig. 1), showing a square-planar complexation geometry, and the single units were found to form a one-dimensional chain structure (Fig. 2). The interactions of these complexes with CT-DNA were studied by different techniques, indicating that they all bind to DNA by classical and/or non-classical intercalation modes.


Subject(s)
Aldehydes/chemistry , Hydrazones/chemistry , Intercalating Agents/chemistry , Organometallic Compounds/chemistry , Copper/chemistry , Crystallography, X-Ray , DNA/chemistry , Hydrazones/chemical synthesis , Intercalating Agents/chemical synthesis , Molecular Structure , Organometallic Compounds/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...